Malaysian Genomics Resource Centre BhdXKLS:0155 +1.89%47 Interest Coverage is 53.55 as of Mar. 2026, which is 9% below its 10-year median of 59.06. GuruFocus rates XKLS:0155 with a GF Score™ of 47/100 and a GF Value™ of RM0.30 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 95 Medical Diagnostics & Research companies, Malaysian Genomics Resource Centre Bhd ranks worse than 1052630.53% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Malaysian Genomics Resource Centre Bhd's
Operating Income
for the
three
months ended in Mar. 2026 was RM1.07 Mil. Malaysian Genomics Resource Centre Bhd's Interest Expense for the
three
months ended in Mar. 2026 was RM-0.02 Mil.
Malaysian Genomics Resource Centre Bhd's interest coverage for the quarter that ended in Mar. 2026 was 53.55.
The higher the ratio, the stronger the company's financial strength is.
XKLS:0155's Interest Coverage is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 9.05 * Ranked among companies with meaningful Interest Coverage only.
Malaysian Genomics Resource Centre Bhd (XKLS:0155) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Malaysian Genomics Resource Centre Bhd Interest Coverage Related Terms
Malaysian Genomics Resource Centre Bhd Interest Coverage Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
Malaysian Genomics Resource Centre Bhd Interest Coverage Chart
Malaysian Genomics Resource Centre Bhd Annual Data
XKLS:0155 vs TMO, DHR, IDXX: Interest Coverage Comparison
For the Diagnostics & Research subindustry, Malaysian Genomics Resource Centre Bhd's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Malaysian Genomics Resource Centre Bhd Interest Coverage vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Malaysian Genomics Resource Centre Bhd's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Malaysian Genomics Resource Centre Bhd's Interest Coverage falls into.
Malaysian Genomics Resource Centre Bhd Interest Coverage Calculation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Malaysian Genomics Resource Centre Bhd (XKLS:0155) has a Interest Coverage of 53.55 as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Malaysian Genomics Resource Centre Bhd and its competitors. This is near median its historical median of 59.06. According to the industry distribution chart, Malaysian Genomics Resource Centre Bhd ranks #999999 out of 95 companies in the Medical Diagnostics & Research industry.
Is Malaysian Genomics Resource Centre Bhd's Interest Coverage too high?
Malaysian Genomics Resource Centre Bhd's current Interest Coverage of 53.55 is near median its 10-year median of 59.06. The Medical Diagnostics & Research industry median Interest Coverage is 9.05. Malaysian Genomics Resource Centre Bhd's value of 53.55 is 491.7% above this industry median. Based on the distribution chart, Malaysian Genomics Resource Centre Bhd ranks #999999 out of 95 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers. Overall, Malaysian Genomics Resource Centre Bhd has a GF Score™ of 47/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Malaysian Genomics Resource Centre Bhd's Interest Coverage compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Malaysian Genomics Resource Centre Bhd ranks #999999 out of 95 companies for Interest Coverage. This places Malaysian Genomics Resource Centre Bhd in the lower half of its industry. The industry median Interest Coverage is 9.05. Malaysian Genomics Resource Centre Bhd's value of 53.55 is 491.7% above this benchmark. While the company's 10-year median is 59.06 vs. the industry median of 9.05, Malaysian Genomics Resource Centre Bhd has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Medical Diagnostics & Research company?
The median Interest Coverage among Medical Diagnostics & Research companies is 9.05, based on 95 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Malaysian Genomics Resource Centre Bhd's current Interest Coverage of 53.55 is 491.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Malaysian Genomics Resource Centre Bhd and its competitors. For the Medical Diagnostics & Research industry, the median Interest Coverage is 9.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Malaysian Genomics Resource Centre Bhd's current Interest Coverage is 53.55, which is near median its own 10-year median of 59.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Malaysian Genomics Resource Centre Bhd stock overvalued right now?
Based on GuruFocus' analysis, Malaysian Genomics Resource Centre Bhd (XKLS:0155) is currently considered Modestly Undervalued. The stock's GF Value™ is RM0.30, compared to a current price of RM0.27 — trading 10% below its estimated fair value. The current Interest Coverage is 53.55, which is near median its 10-year median of 59.06 and 491.7% above the Medical Diagnostics & Research industry median of 9.05. Malaysian Genomics Resource Centre Bhd's overall GF Score™ is 47/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Malaysian Genomics Resource Centre Bhd (XKLS:0155), the current Interest Coverage is 53.55 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Malaysian Genomics Resource Centre Bhd (XKLS:0155) Overvalued in 2026?
Based on GuruFocus' analysis, Malaysian Genomics Resource Centre Bhd stock appears to be undervalued.
The current stock price of RM0.27 is trading 10% below its estimated GF Value™ of RM0.30.
GuruFocus considers Malaysian Genomics Resource Centre Bhd to be Modestly Undervalued.
Key valuation signals for XKLS:0155:
Interest Coverage: 53.55 (near median its 10-year median of 59.06)
GF Value™: RM0.30 vs. price of RM0.27 (10% below fair value)
Industry Position: 491.7% above the Medical Diagnostics & Research median (#999999 of 95)
No single metric tells the full story. See the XKLS:0155 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Malaysian Genomics Resource Centre Bhd Business Description
Malaysian Genomics Resource Centre Bhd is a Malaysia-based company. The company's principal activities include enabling personalized and precision medicine through genetics, genomics, immunotherapy, and biopharmaceutical services, as well as investment holding. It offers genome sequencing and analysis (GSA) services and genetic screening services (GSS). The group offerings include precision genetic screening, project-based analysis, and high-quality cell therapy and cosmeceutical products. The reportable segments of the Group derive their revenue from the provision of personalised and precision medicine through genetics, genomics, immunotherapy, and biopharmaceutical services within the healthcare segment.
47GF Score
Get the complete analysis for XKLS:0155
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:0155 has been successfully added to your 
